Gut-liver axis: Pathophysiological concepts and clinical implications

H Tilg, TE Adolph, M Trauner - Cell metabolism, 2022 - cell.com
Bidirectional crosstalk along the gut-liver axis controls gastrointestinal health and disease
and exploits environmental and host mediators. Nutrients, microbial antigens, metabolites …

Liver fibrosis: mechanistic concepts and therapeutic perspectives

N Roehlen, E Crouchet, TF Baumert - Cells, 2020 - mdpi.com
Liver fibrosis due to viral or metabolic chronic liver diseases is a major challenge of global
health. Correlating with liver disease progression, fibrosis is a key factor for liver disease …

The gut-liver axis in liver disease: Pathophysiological basis for therapy

A Albillos, A De Gottardi, M Rescigno - Journal of hepatology, 2020 - Elsevier
The gut-liver axis refers to the bidirectional relationship between the gut and its microbiota,
and the liver, resulting from the integration of signals generated by dietary, genetic and …

Role of liver sinusoidal endothelial cells in liver diseases

J Gracia-Sancho, E Caparrós… - Nature reviews …, 2021 - nature.com
Liver sinusoidal endothelial cells (LSECs) form the wall of the hepatic sinusoids. Unlike
other capillaries, they lack an organized basement membrane and have cytoplasm that is …

Breakthroughs in therapies for NASH and remaining challenges

V Ratziu, S Francque, A Sanyal - Journal of hepatology, 2022 - Elsevier
Initially a condition that received limited recognition and whose clinical impact was
controversial, non-alcoholic steatohepatitis (NASH) has become a leading cause of chronic …

Liver fibrosis: therapeutic targets and advances in drug therapy

Z Tan, H Sun, T Xue, C Gan, H Liu, Y Xie… - Frontiers in cell and …, 2021 - frontiersin.org
Liver fibrosis is an abnormal wound repair response caused by a variety of chronic liver
injuries, which is characterized by over-deposition of diffuse extracellular matrix (ECM) and …

[HTML][HTML] Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy

Y Iwakiri, J Trebicka - JHEP reports, 2021 - Elsevier
Portal hypertension, defined as increased pressure in the portal vein, develops as a
consequence of increased intrahepatic vascular resistance due to the dysregulation of liver …

Gut microbiota and hypertension: association, mechanisms and treatment

Z Yang, Q Wang, Y Liu, L Wang, Z Ge, Z Li… - Clinical and …, 2023 - Taylor & Francis
Objectives Hypertension is one of the most important risk factors for cardio-cerebral vascular
diseases, which brings a heavy economic burden to society and becomes a major public …

FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis

M Sorribas, MO Jakob, B Yilmaz, H Li, D Stutz… - Journal of …, 2019 - Elsevier
Background & Aims Pathological bacterial translocation (PBT) in cirrhosis is the hallmark of
spontaneous bacterial infections, increasing mortality several-fold. Increased intestinal …

[HTML][HTML] Treatment options for alcoholic and non-alcoholic fatty liver disease: A review

S Singh, NA Osna, KK Kharbanda - World journal of …, 2017 - ncbi.nlm.nih.gov
Alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD) are serious
health problems worldwide. These two diseases have similar pathological spectra, ranging …